Leptin augments coronary vasoconstriction and smooth muscle proliferation via a Rho-kinase-dependent pathway

Basic Research in Cardiology

Volumn 111, Issue 3, 2016, Pages

  Noblet, Jillian N ^a   Goodwill, Adam G ^a   Sassoon, Daniel J ^a   Kiel, Alexander M ^a,b   Tune, Johnathan D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Coronary; Leptin; Rho kinase

Indexed keywords

LEPTIN; PROTEOME; RHO KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY MUSCLE; DEPOLARIZATION; DOWN REGULATION; ENZYME INHIBITION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; CORONARY BLOOD VESSEL; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; PIG; VASOCONSTRICTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CORONARY VESSELS; LEPTIN; MASS SPECTROMETRY; MUSCLE, SMOOTH, VASCULAR; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SWINE; VASOCONSTRICTION;

EID: 84960982029     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-016-0545-6     Document Type: Article

References (56)

1. Bain J, Plater L, Elliott M, Shpiro N, Hastie C, McLauchlan H, Klevernic I, Arthur J, Alessi D, Cohen P (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408:297–315. doi:10.1042/BJ20070797
2. Beltowski J (2006) Leptin and atherosclerosis. Atherosclerosis 189:47–60. doi:10.1016/j.atherosclerosis.2006.03.003
3. Beltowski J (2012) Leptin and the regulation of endothelial function in physiological and pathological conditions. Clin Exp Pharmacol Physiol 39:168–178. doi:10.1111/j.1440-1681.2011.05623.x
4. V1.2 channels to coronary dysfunction in obesity. Basic Res Cardiol 108:370. doi:10.1007/s00395-013-0370-0
5. Berwick ZC, Dick GM, Tune JD (2012) Heart of the matter: coronary dysfunction in metabolic syndrome. J Mol Cell Cardiol 52:848–856. doi:10.1016/j.yjmcc.2011.06.025
6. Bohlen F, Kratzsh J, Mueller M, Seidel B, Friedman-Einat M, Witzigmann H, Teupser D, Koerner A, Storck M, Thiery J (2007) Leptin inhibits cell growth of human vascular smooth muscle cells. Vasc Pharmacol 46:67–71. doi:10.1016/j.vph.2006.06.014
7. Bouloumie A, Marumo T, Lafontan M, Busse R (1999) Leptin induces oxidative stress in human endothelial cells. FASEB J 13:1231–1238
8. Brown NK, Zhou Z, Zhang J, Zeng R, Wu J, Eitzman DT, Chen YE, Chang L (2014) Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol 34:1621–1630. doi:10.1161/ATVBAHA.114.303029
9. Chatterjee TK, Aronow BJ, Tong WS, Manka D, Tang Y, Bogdanov VY, Unruh D, Blomkalns AL, Piegore MGJ, Weintraub DS, Rudiche SM, Kuhel DG, Hui DY, Weintraub NL (2013) Human coronary artery perivascular adipocytes overexpress genes responsible for regulating vascular morphology, inflammation, and hemostasis. Physiol Genom 45:697–709. doi:10.1152/physiolgenomics.00042
10. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, Rudich S, Weintraub NL (2009) Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 104:541–549. doi:10.1161/CIRCRESAHA.108.182998
11. Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, Voon WC, Sheu SH, Lai WT (2008) Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 32:268–274. doi:10.1038/sj.ijo.0803726
12. Davies S, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95–105
13. Drolet R, Belanger C, Fortier M, Huot C, Mailloux J, Legare D, Tchernof A (2009) Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring) 17:424–430. doi:10.1038/oby.2008.555
14. Fortuno A, Rodriguez A, Gomez-Ambrosi J, Muniz P, Salvador J, Diez J, Fruhbeck G (2002) Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology 143:3555–3560. doi:10.1210/en.2002-220075
15. Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763–770. doi:10.1038/27376
16. Gollasch M (2012) Vasodilator signals from perivascular adipose tissue. Br J Pharmacol 165:633–642. doi:10.1111/j.1476-5381.2011.01430.x
17. Gorter PM, van Lindert AS, de Vos AM, Meijs MF, van der Graaf Y, Doevendans PA, Prokop M, Visseren FL (2008) Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 197:896–903. doi:10.1016/j.atherosclerosis.2007.08.016
18. Gruen M, Hao M, Piston D, Hasty A (2007) Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxsis. Am J Physiol Cell Physiol 293:C1481–C1488. doi:10.1152/ajpcell.00062.2007
19. Huang F, Xiong X, Wang H, You S, Zneg H (2010) Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kB. Acta Biochim Biophys Sin 42:325–331. doi:10.1093/abbs/gmq025
20. Knudson JD, Dincer UD, Zhang C, Swafford AN Jr, Koshida R, Picchi A, Focardi M, Dick GM, Tune JD (2005) Leptin receptors are expressed in coronary arteries and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol. doi:10.1152/ajpheart.01159.2004
21. Korda M, Kubant R, Patton S, Malinski T (2008) Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 295:H1514–H1521. doi:10.1152/ajpheart.00479.2008
22. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288:H2031–H2041. doi:10.1152/ajpheart.01058.2004
23. Lin YC, Huang J, Kan H, Castranova V, Frisbee JC, Yu HG (2012) Defective calcium inactivation causes long QT in obese insulin-resistant rat. Am J Physiol Heart Circ Physiol 302:H1013–H1022. doi:10.1152/ajpheart.00837.2011
24. Liu B, Itoh H, Louie O, Kubota K, Kent K (2002) The signaling protein Rho is necesary for vascular smooth muscle migration and survival but not for proliferation. Surgery 132:317–325. doi:10.1067/msy.2002.125786
25. Loirand G, Guerin P, Pacaud P (2006) Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98:322–334. doi:10.1161/01.RES.0000201960.04223.3c
26. Mazurek T, Zhang L, Zalewski A, Mannion D, Diehl J, Arafat H, Sarov-Blat L, O’Brien S, Keiper E, Johnson A, Martin J, Goldstein B, Shi Y (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108:2460–2466. doi:10.1161/01.CIR.0000099542.57313.C5
27. + channels. Arterioscler Thromb Vasc Biol 35:1393–1400. doi:10.1161/ATVBAHA.115.305500
28. Oda A, Taniguchi T, Yokoyama M (2001) Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 47:141–150
29. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97. doi:10.1038/nri2921
30. Owen MK, Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP, Alloosh M, Sturek M, Tune JD (2013) Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation 128:9–18. doi:10.1161/CIRCULATIONAHA.112.001238
31. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767–801. doi:10.1152/physrev.00041.2003
32. Ozer C, Gulen S, Dilekoz E, Babul A, Ercan ZS (2006) The effect of systemic leptin administration on aorta smooth muscle responses in diabetic rats. Mol Cell Biochem 282:187–191. doi:10.1007/s11010-006-1927-0
33. Pardina E, Ferrer R, Baena-Fustegueras J, Lecube A, Fort J, Vargas V, Catalan R, Peinado-Onsurbe J (2010) The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obes Surg 40:623–632. doi:10.1007/s11695-010-0103-5
34. Payne GA, Bohlen HG, Dincer UD, Borbouse L, Tune JD (2009) Periadventitial adipose tissue impairs coronary endothelial function via PKC-beta-dependent phosphorylation of nitric oxide synthase. Am J Physiol Heart Circ Physiol 297:H460–H465. doi:10.1152/ajpheart.00116.2009
35. Payne GA, Borbouse L, Bratz IN, Roell WC, Bohlen HG, Dick GM, Tune JD (2008) Endogenous adipose-derived factors diminish coronary endothelial function via inhibition of nitric oxide synthase. Microcirculation 15:417–426. doi:10.1080/10739680701858447
36. Payne GA, Borbouse L, Kumar S, Neeb Z, Alloosh M, Sturek M, Tune JD (2010) Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-β pathway. Arterioscler Thromb Vasc Biol 30:1711–1717. doi:10.1161/ATVBAHA.110.210070
37. Rikitake Y, Kim H, Huang Z, Seto M, Yano K, Asano T, Moskowitz M, Liao J (2005) Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36:2251–2257. doi:10.1161/01.STR.0000181077.84981.11
38. Rodriguez A, Fortuno A, Gomez-Ambrosi J, Zalba G, Diez J, Fruhbeck G (2007) The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 148:324–331. doi:10.1210/en.2006-0940
39. Rodriguez A, Fruhbeck G, Gomez-Ambrosi J, Catalan V, Sainz N, Zalba G, Fortuno A (2006) The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats. J Hypertens 24:1589–1597. doi:10.1097/01.hjh.0000239295.17636.6e
40. Rodriguez A, Gomez-Ambrosi J, Catalan V, Fortuno A, Fruhbeck G (2010) Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanisms. Mediat Inflamm. doi:10.1155/2010/105489
41. Samora JB, Goodwill AG, Frisbee JC, Boegehold MA (2010) Growth-dependent changes in the contribution of carbon monoxide to arteriolar function. J Vasc Res 47:23–24. doi:10.1159/000231718
42. Schafer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff D, Konstantinides S (2004) Leptin promtoes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 24:112–117. doi:10.1161/01.ATV.0000105904.02142.e7
43. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White D, Hartenstein V, Eliceiri K, Tomanack P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. doi:10.1038/nmeth.2019
44. Schroeter MR, Eschholz N, Herzberg S, Jerchel I, Leifheif-Nestler M, Czepluch FS, Chalikias G, Konstantinides S, Shafer K (2013) Leptin-dependent and leptin-independent paracrine effects of perivascualr adipose tissue on neointima formation. Arterioscler Thromb Vasc Biol 33:980–987. doi:10.1161/ATVBAHA.113.301393
45. Shan J, Nguyen TB, Totary-Jain H, Dansky H, Marx SO, Marks AR (2008) Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proc Natl Acad Sci 105:19006–19011. doi:10.1073/pnas.0809743105
46. Shek EW, Brands MW, Hall JE (1998) Chronic leptin infusion increases arterial pressure. Hypertension 31:409–414. doi:10.1161/01.HYP.31.1.409
47. Shibasaki I, Nishikimi T, Mochizuki Y, Yamada Y, Yoshitatsu M, Inoue Y, Kuwata T, Ogawa H, Tsuchiya G, Ishimitsu T, Fukuda H (2010) Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease. Regul Pept 165:210–217. doi:10.1016/j.regpep.2010.07.169
48. Shibata R, Kai H, Seki Y, Kato S, Morimatsu M, Kaibuchi K, Imaizumi T (2001) Role of Rho-associated kinase in neointima formation after vascular injury. Circulation 103:284–289. doi:10.1161/01.CIR.103.2.284
49. Shin HJ, Oh J, Kang SM, Lee JH, Shin MJ, Hwang KC, Jang Y, Chung JH (2005) Leptin induces hypertrophy via p38 mitogen-activated protein kinase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 329:18–24. doi:10.1016/j.bbrc.2004.12.195
50. Sturek M (2011) Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes. J Appl Physiol 111:573–586. doi:10.1152/japplphysiol.00373
51. Tano JY, Schleifenbaum J, Gollasch M (2014) Perivascular adipose tissue, potassium channels, and vascular dysfunction. Arterscler Thromb Vasc Biol 34:1827–1830. doi:10.1161/ATVBAHA.114.303032
52. 2+ channels modulate expression of smooth muscle differentiation marker genes via a Rho kinase/myocardin/SRF-dependent mechanism. Circ Res 95:406–414. doi:10.1161/01.RES.0000138582.36921.9e
53. Withers SB, Bussey CE, Saxton SN, Melrose HM, Watkins AE, Heagerty AM (2014) Mechanisms of adiponectin-associated perivascular function in vascular disease. Arterioscler Thromb Vasc Biol 34:1637–1642. doi:10.1161/ATVBAHA.114.303031
54. Zeidan A, Javadov S, Chakrabarti S, Karmazyn M (2008) Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res 77:64–72. doi:10.1093/cvr/cvm020
55. Zeidan A, Javadov S, Karmazyn M (2006) Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes. Cardiovasc Res 72:101–111. doi:10.1016/j.cardiores.2006.06.024
56. Zeidan A, Paylor B, Steinhoff K, Javadov S, Rajapurohitam V, Chakrabarti S, Karmazyn M (2007) Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways. J Pharmacol Exp Ther 322:1110–1116. doi:10.1124/jpet.107.122440